AURA BIOSCIENCES, INC.

Company

Aura Biosciences, Inc.

Filed

November 4, 2021

Accession Number

0000902664-21-004741

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →